2022
Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
Harris L, L’Italien G, Kumar A, Seelam P, LaVallee C, Coric V, Lipton R. Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States. Headache The Journal Of Head And Face Pain 2022, 62: 473-481. PMID: 35343590, PMCID: PMC9313575, DOI: 10.1111/head.14289.Peer-Reviewed Original ResearchConceptsMigraine-related disabilityDirect medical costsMedical costsIVB patientsEpisodic migrainePharmacy costsGrade IMigraine Disability Assessment Scale (MIDAS) questionnaireMigraine Disability Assessment ScoreHealthcare resource utilizationMigraine Disability AssessmentPrimary care settingElectronic health record dataSubstantial economic burdenHigher medical costsHealth record dataPublic health concernCost-effective treatmentRevision 9Cohort studyHealthcare visitsMIDAS scoreMigraine disabilitySpecialty careReal-world assessment
2021
Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
Johnston K, L’Italien G, Popoff E, Powell L, Croop R, Thiry A, Harris L, Coric V, Lipton R. Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant. Advances In Therapy 2021, 38: 5209-5220. PMID: 34455556, PMCID: PMC8478726, DOI: 10.1007/s12325-021-01897-2.Peer-Reviewed Original ResearchConceptsMonthly migraine daysPRN groupMigraine-Specific QualityEQ-5DPRN armLong-term safety studiesHealth state utilitiesMigraine daysEpisodic migraineMethodsStudy participantsTreatment regimensWeek 12Study visitNeurological conditionsSafety studiesBaselineDay scheduleState utilitiesPatientsUtility valuesPRNOutcomesQODGroupDays